Insights into the potential use of microRNAs as biomarker in cancer

International Journal of Surgery

Volumn 10, Issue 9, 2012, Pages 443-449

  Anindo, Mohammad Iffat Kabir ^a   Yaqinuddin, Ahmed ^a  

^a ALFAISAL UNIVERSITY   (Saudi Arabia)

Author keywords

Biomarkers; Gene regulation; MicroRNA; Tumor markers

Indexed keywords

MICRORNA; MICRORNA 1; MICRORNA 106; MICRORNA 107; MICRORNA 122; MICRORNA 124; MICRORNA 125B; MICRORNA 126; MICRORNA 133; MICRORNA 140; MICRORNA 143; MICRORNA 145; MICRORNA 155; MICRORNA 192; MICRORNA 199; MICRORNA 205; MICRORNA 208; MICRORNA 21; MICRORNA 221; MICRORNA 224; MICRORNA 296; MICRORNA 30D; MICRORNA 34A; MICRORNA 355; MICRORNA 375; MICRORNA 449; MICRORNA 484; MICRORNA 690; RNA; TUMOR MARKER; UNCLASSIFIED DRUG;

APOPTOSIS; B CELL LYMPHOMA; BIOGENESIS; BREAST CANCER; CANCER DIAGNOSIS; CELL DIFFERENTIATION; CELL MATURATION; CELL METABOLISM; CELL PROLIFERATION; COLON CANCER; DIAGNOSTIC VALUE; ESOPHAGUS CANCER; GENE CONTROL; GENE DELETION; HEAD AND NECK CANCER; HUMAN; LEUKEMIA; LIVER CELL CARCINOMA; LUNG CANCER; MELANOMA; MICROARRAY ANALYSIS; NEOPLASM; OVARY CARCINOMA; PANCREAS CANCER; PATHOGENESIS; PRIORITY JOURNAL; PROSTATE CANCER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; RHABDOMYOSARCOMA; SENSITIVITY AND SPECIFICITY; STOMACH CANCER;

GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84867897057     PISSN: 17439191     EISSN: 17439159     Source Type: Journal    
DOI: 10.1016/j.ijsu.2012.08.006     Document Type: Review

References (112)

1. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
2. Davis B.N., Hata A. Regulation of microRNA biogenesis: a miRiad of mechanisms. Cell Commun Signal 2009, 7:18.
3. Lee R.C., Feinbaum R.L., Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993, 75:843-854.
4. Wheeler B.M., Heimberg A.M., Moy V.N., Sperling E.A., Holstein T.W., Heber S., et al. The deep evolution of metazoan microRNAs. Evol Dev 2009, 11:50-68.
5. Flynt A.S., Lai E.C. Biological principles of microRNA-mediated regulation: shared themes amid diversity. Nat Rev Genet 2008, 9:831-842.
6. Peter M.E. Let-7 and miR-200 microRNAs: guardians against pluripotency and cancer progression. Cell Cycle (Georgetown, Tex) 2009, 8:843-852.
7. Pineau P., Volinia S., McJunkin K., Marchio A., Battiston C., Terris B., et al. miR-221 overexpression contributes to liver tumorigenesis. Proc Natl Acad Sci USA 2010, 107:264-269.
8. Wurz K., Garcia R.L., Goff B.A., Mitchell P.S., Lee J.H., Tewari M., et al. MiR-221 and MiR-222 alterations in sporadic ovarian carcinoma: relationship to CDKN1B, CDKNIC and overall survival. Genes, Chromosomes & Cancer 2010, 49:577-584.
9. Zhang J., Han L., Ge Y., Zhou X., Zhang A., Zhang C., et al. miR-221/222 promote malignant progression of glioma through activation of the Akt pathway. Int Journal Oncology 2010, 36:913-920.
10. Lee Y., Jeon K., Lee J.T., Kim S., Kim V.N. MicroRNA maturation: stepwise processing and subcellular localization. Embo J 2002, 21:4663-4670.
11. Hutvagner G., McLachlan J., Pasquinelli A.E., Balint E., Tuschl T., Zamore P.D., et al. A cellular function for the RNA-interference enzyme dicer in the maturation of the let-7 small temporal RNA. Science 2001, 293:834-838.
12. Lee Y., Kim M., Han J., Yeom K.H., Lee S., Baek S.H., et al. MicroRNA genes are transcribed by RNA polymerase II. Embo J 2004, 23:4051-4060.
13. Lee Y., Ahn C., Han J., Choi H., Kim J., Yim J., et al. The nuclear RNase III Drosha initiates microRNA processing. Nature 2003, 425:415-419.
14. Yi R., Qin Y., Macara I.G., Cullen B.R. Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev 2003, 17:3011-3016.
15. He L., Hannon G.J. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 2004, 5:522-531.
16. Chen X., Liang H., Zhang J., Zen K., Zhang C.Y. Horizontal transfer of microRNAs: molecular mechanisms and clinical applications. Protein & Cell 2012, 3:28-37.
17. Turchinovich A., Weiz L., Langheinz A., Burwinkel B. Characterization of extracellular circulating microRNA. Nucleic Acids Research 2011, 39:7223-7233.
18. Valadi H., Ekstrom K., Bossios A., Sjostrand M., Lee J.J., Lotvall J.O., et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biology 2007, 9:654-659.
19. Vickers K.C., Palmisano B.T., Shoucri B.M., Shamburek R.D., Remaley A.T. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biology 2011, 13:423-433.
20. Wang K., Zhang S., Weber J., Baxter D., Galas D.J. Export of microRNAs and microRNA-protective protein by mammalian cells. Nucleic Acids Research 2010, 38:7248-7259.
21. Zernecke A., Bidzhekov K., Noels H., Shagdarsuren E., Gan L., Denecke B., et al. Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Sci Signaling 2009, 2:ra81.
22. Berezikov E., Guryev V., van de Belt J., Wienholds E., Plasterk R.H., Cuppen E., et al. Phylogenetic shadowing and computational identification of human microRNA genes. Cell 2005, 120:21-24.
23. Schickel R., Boyerinas B., Park S.M., Peter M.E. MicroRNAs: key players in the immune system, differentiation, tumorigenesis and cell death. Oncogene 2008, 27:5959-5974.
24. Lewis B.P., Burge C.B., Bartel D.P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005, 120:15-20.
25. Lim L.P., Lau N.C., Garrett-Engele P., Grimson A., Schelter J.M., Castle J., et al. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 2005, 433:769-773.
26. Cai B., Pan Z., Lu Y. The roles of microRNAs in heart diseases: a novel important regulator. Curr Medicinal Chemistry 2010, 17:407-411.
27. Martin M.M., Lee E.J., Buckenberger J.A., Schmittgen T.D., Elton T.S. MicroRNA-155 regulates human angiotensin II type 1 receptor expression in fibroblasts. J Biological Chemistry 2006, 281:18277-18284.
28. Kato M., Zhang J., Wang M., Lanting L., Yuan H., Rossi J.J., et al. MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-beta-induced collagen expression via inhibition of E-box repressors. Proc Natl Acad Sci USA 2007, 104:3432-3437.
29. Akkina S., Becker B.N. MicroRNAs in kidney function and disease. Transl Res 2011, 157:236-240.
30. El Ouaamari A., Baroukh N., Martens G.A., Lebrun P., Pipeleers D., Van Obberghen E., et al. miR-375 targets 3'-phosphoinositide-dependent protein kinase-1 and regulates glucose-induced biological responses in pancreatic beta-cells. Diabetes 2008, 57:2708-2717.
31. Lovis P., Roggli E., Laybutt D.R., Gattesco S., Yang J.Y., Widmann C., et al. Alterations in microRNA expression contribute to fatty acid-induced pancreatic beta-cell dysfunction. Diabetes 2008, 57:2728-2736.
32. Tang X., Muniappan L., Tang G., Ozcan S. Identification of glucose-regulated miRNAs from pancreatic {beta} cells reveals a role for miR-30d in insulin transcription. RNA (New York, NY) 2009, 15:287-293.
33. Poy M.N., Hausser J., Trajkovski M., Braun M., Collins S., Rorsman P., et al. miR-375 maintains normal pancreatic alpha- and beta-cell mass. Proc Natl Acad Sci USA 2009, 106:5813-5818.
34. Calin G.A., Sevignani C., Dumitru C.D., Hyslop T., Noch E., Yendamuri S., et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA 2004, 101:2999-3004.
35. Zhang W., Dahlberg J.E., Tam W. MicroRNAs in tumorigenesis: a primer. Am J Pathol 2007, 171:728-738.
36. Calin G.A., Croce C.M. MicroRNA-cancer connection: the beginning of a new tale. Cancer Res 2006, 66:7390-7394.
37. Calin G.A., Ferracin M., Cimmino A., Di Leva G., Shimizu M., Wojcik S.E., et al. A microRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 2005, 353:1793-1801.
38. Tagawa H., Seto M. A microRNA cluster as a target of genomic amplification in malignant lymphoma. Leukemia 2005, 19:2013-2016.
39. Giannakakis A., Sandaltzopoulos R., Greshock J., Liang S., Huang J., Hasegawa K., et al. miR-210 links hypoxia with cell cycle regulation and is deleted in human epithelial ovarian cancer. Cancer Biol Ther 2008, 7:255-264.
40. Zhang L., Huang J., Yang N., Greshock J., Megraw M.S., Giannakakis A., et al. MicroRNAs exhibit high frequency genomic alterations in human cancer. Proc Natl Acad Sci USA 2006, 103:9136-9141.
41. Iorio M.V., Visone R., Di Leva G., Donati V., Petrocca F., Casalini P., et al. MicroRNA signatures in human ovarian cancer. Cancer Res 2007, 67:8699-8707.
42. Saito Y., Liang G., Egger G., Friedman J.M., Chuang J.C., Coetzee G.A., et al. Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. Cancer Cell 2006, 9:435-443.
43. Kumar M.S., Lu J., Mercer K.L., Golub T.R., Jacks T. Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat Genet 2007, 39:673-677.
44. Calin G.A., Croce C.M. MicroRNA signatures in human cancers. Nat Rev Cancer 2006, 6:857-866.
45. Lu J., Getz G., Miska E.A., Alvarez-Saavedra E., Lamb J., Peck D., et al. MicroRNA expression profiles classify human cancers. Nature 2005, 435:834-838.
46. Johnson S.M., Grosshans H., Shingara J., Byrom M., Jarvis R., Cheng A., et al. RAS is regulated by the let-7 microRNA family. Cell 2005, 120:635-647.
47. Cimmino A., Calin G.A., Fabbri M., Iorio M.V., Ferracin M., Shimizu M., et al. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci USA 2005, 102:13944-13949.
48. Le Sage C., Nagel R., Egan D.A., Schrier M., Mesman E., Mangiola A., et al. Regulation of the p27(Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation. Embo J 2007, 26:3699-3708.
49. Mitchell P.S., Parkin R.K., Kroh E.M., Fritz B.R., Wyman S.K., Pogosova-Agadjanyan E.L., et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 2008, 105:10513-10518.
50. Chen X., Ba Y., Ma L., Cai X., Yin Y., Wang K., et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Research 2008, 18:997-1006.
51. Cortez M.A., Calin G.A. MicroRNA identification in plasma and serum: a new tool to diagnose and monitor diseases. Expert Opinion Biological Therapy 2009, 9:703-711.
52. Lawrie C.H., Gal S., Dunlop H.M., Pushkaran B., Liggins A.P., Pulford K., et al. Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br J Haematol 2008, 141:672-675.
53. Huang Z., Huang D., Ni S., Peng Z., Sheng W., Du X., et al. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int Journal Cancer 2010, 127:118-126.
54. Lodes M.J., Caraballo M., Suciu D., Munro S., Kumar A., Anderson B., et al. Detection of cancer with serum miRNAs on an oligonucleotide microarray. PloS One 2009, 4:e6229.
55. Resnick K.E., Alder H., Hagan J.P., Richardson D.L., Croce C.M., Cohn D.E., et al. The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform. Gynecol Oncol 2009, 112:55-59.
56. Moltzahn F., Olshen A.B., Baehner L., Peek A., Fong L., Stoppler H., et al. Microfluidic-based multiplex qRT-PCR identifies diagnostic and prognostic microRNA signatures in the sera of prostate cancer patients. Cancer Research 2010, 71:550-560.
57. Asaga S., Kuo C., Nguyen T., Terpenning M., Giuliano A.E., Hoon D.S., et al. Direct serum assay for microRNA-21 concentrations in early and advanced breast cancer. Clin Chemistry 2011, 57:84-91.
58. Heneghan H.M., Miller N., Lowery A.J., Sweeney K.J., Newell J., Kerin M.J., et al. Circulating microRNAs as novel minimally invasive biomarkers for breast cancer. Ann Surg 2010, 251:499-505.
59. Zhao H., Shen J., Medico L., Wang D., Ambrosone C.B., Liu s A pilot study of circulating miRNAs as potential biomarkers of early stage breast cancer. PloS One 2010, 5:e13735.
60. Zhu W., Qin W., Atasoy U., Sauter E.R. Circulating microRNAs in breast cancer and healthy subjects. BMC Research Notes 2009, 2:89.
61. Chung G.E., Yoon J.H., Myung S.J., Lee J.H., Lee S.H., Lee S.M. High expression of microRNA-15b predicts a low risk of tumor recurrence following curative resection of hepatocellular carcinoma. Oncol Rep 2010, 23:113-119.
62. Garzon R., Volinia S., Liu C.G., Fernandez-Cymering C., Palumbo T., Pichiorri F., et al. MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia. Blood 2008, 111:3183-3189.
63. Ji J., Zhao L., Budhu A., Forgues M., Jia H.L., Qin L.X., et al. Let-7g targets collagen type I alpha2 and inhibits cell migration in hepatocellular carcinoma. J Hepatol 2010, 52:690-697.
64. Jiang J., Gusev Y., Aderca I., Mettler T.A., Nagorney D.M., Brackett D.J., et al. Association of microRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival. Clin Cancer Res 2008, 14:419-427.
65. Schetter A.J., Leung S.Y., Sohn J.J., Zanetti K.A., Bowman E.D., Yanaihara N., et al. MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. Jama 2008, 299:425-436.
66. Yanaihara N., Caplen N., Bowman E., Seike M., Kumamto K., Yi M., et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 2006, 9:189-198.
67. Budhu A., Jia H.L., Forgues M., Liu C.G., Goldstein D., Lam A., et al. Identification of metastasis-related microRNAs in hepatocellular carcinoma. Hepatol (Baltimore, Md) 2008, 47:897-907.
68. Coulouarn C., Factor V.M., Andersen J.B., Durkin M.E., Thorgeirsson S.S. Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties. Oncogene 2009, 28:3526-3536.
69. Huang Q., Gumireddy K., Schrier M., Le Sage C., Nagel R., Nair S., et al. The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis. Nat Cell Biol 2008, 10:202-210.
70. Negrini M., Calin G.A. Breast cancer metastasis: a microRNA story. Breast Cancer Res 2008, 10:203.
71. Tavazoie S.F., Alarcon C., Oskarsson T., Padua D., Wang Q., Bos P.D., et al. Endogenous human microRNAs that suppress breast cancer metastasis. Nature 2008, 451:147-152.
72. Zenz T., Mohr J., Eldering E., Kater A.P., Bühler A., Kienle D., et al. miR-34a as part of the resistance network in chronic lymphocytic leukemia. Blood 2009, 113:3801-3808.
73. Spahn M., Kneitz S., Scholz C.J., Stenger N., Rüdiger T., Ströbel P., et al. Expression of microRNA-221 is progressively reduced in aggressive prostate cancer and metastasis and predicts clinical recurrence. Int Journal Cancer 2010, 127:394-403.
74. Maru D.M., Singh R.R., Hannah C., Albarracin C.T., Li Y.X., Abraham R., et al. MicroRNA-196a is a potential marker of progression during Barrett's metaplasia-dysplasia-invasive adenocarcinoma sequence in esophagus. Am J Pathol 2009, 174:1940-1948.
75. Ng E.K., Chong W.W., Jin H., Lam E.K., Shin V.Y., Yu J., et al. Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut 2009, 58:1375-1381.
76. Tanaka M., Oikawa K., Takanashi M., Kudo M., Ohyashiki J., Ohyashiki K., et al. Down-regulation of miR-92 in human plasma is a novel marker for acute leukemia patients. PloS One 2009, 4:e5532.
77. Wang J., Chen J., Chang P., LeBlanc A., Li D., Abbruzzesse J.L., et al. MicroRNAs in plasma of pancreatic ductal adenocarcinoma patients as novel blood-based biomarkers of disease. Cancer Prevention Research (Philadelphia, Pa) 2009, 2:807-813.
78. Murakami Y., Yasuda T., Saigo K., Urashima T., Toyoda H., Okanoue T., et al. Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene 2006, 25:2537-2545.
79. Tazawa H., Tsuchiya N., Izumiya M., Nakagama H. Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells. Proc Natl Acad Sci USA 2007, 104:15472-15477.
80. Zhu S., Wu H., Wu F., Nie D., Sheng S., Mo Y.Y., et al. MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Research 2008, 18:350-359.
81. Mattie M.D., Benz C.C., Bowers J., Sensinger K., Wong L., Scott G.K., et al. Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies. Mol Cancer 2006, 5:24.
82. Ambs S., Prueitt R.L., Yi M., Hudson R.S., Howe T.M., Petrocca F., et al. Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer. Cancer Res 2008, 68:6162-6170.
83. Noonan E.J., Place R.F., Pookot D., Basak S., Whitson J.M., Hirata H., et al. miR-449a targets HDAC-1 and induces growth arrest in prostate cancer. Oncogene 2009, 28:1714-1724.
84. Fuse M., Nohata N., Kojima S., Sakamoto S., Chiyomaru T., Kawakami K., et al. Restoration of miR-145 expression suppresses cell proliferation, migration and invasion in prostate cancer by targeting FSCN1. Int Journal Oncology 2011, 38:1093-1101.
85. Gandellini P., Folini M., Longoni N., Pennati M., Binda M., Colecchia M., et al. miR-205 exerts tumor-suppressive functions in human prostate through down-regulation of protein kinase Cepsilon. Cancer Research 2009, 69:2287-2295.
86. Gandellini P., Profumo V., Casamichele A., Fenderico N., Borrelli S., Petrovich G., et al. miR-205 regulates basement membrane deposition in human prostate: implications for cancer development. Cell Death Differentiation 2012.
87. Li T., Li D., Sha J., Sun P., Huang Y. MicroRNA-21 directly targets MARCKS and promotes apoptosis resistance and invasion in prostate cancer cells. Biochem Biophysical Research Communications 2009, 383:280-285.
88. Zaman M.S., Chen Y., Deng G., Shahryari V., Suh S.O., Saini S., et al. The functional significance of microRNA-145 in prostate cancer. Br Journal Cancer 2010, 103:256-264.
89. Majid S., Dar A.A., Saini S., Yamamura S., Hirata H., Tanaka Y., et al. MicroRNA-205-directed transcriptional activation of tumor suppressor genes in prostate cancer. Cancer 2010, 116:5637-5649.
90. Aqeilan R.I., Calin G.A., Croce C.M. miR-15a and miR-16-1 in cancer: discovery, function and future perspectives. Cell Death Differentiation 2010, 17:215-220.
91. Schramedei K., Morbt N., Pfeifer G., Läuter J., Rosolowski M., Tomm J.M., et al. MicroRNA-21 targets tumor suppressor genes ANP32A and SMARCA4. Oncogene 2011, 30:2975-2985.
92. Liu L.Z., Li C., Chen Q., Jing Y., Carpenter R., Jiang Y., et al. MiR-21 induced angiogenesis through AKT and ERK activation and HIF-1alpha expression. PloS One 2011, 6:e19139.
93. Eder M., Scherr M. MicroRNA and lung cancer. N Engl J Med 2005, 352:2446-2448.
94. Spizzo R., Nicoloso M.S., Croce C.M., Calin G.A. SnapShot: microRNAs in cancer. Cell 2009, 137:586-e1.
95. Ebi H., Sato T., Sugito N., Hosono Y., Yatabe Y., Matsuyama Y., et al. Counterbalance between RB inactivation and miR-17-92 overexpression in reactive oxygen species and DNA damage induction in lung cancers. Oncogene 2009, 28:3371-3379.
96. Bryant R.J., Pawlowski T., Catto J.W., Marsden G., Vessella R.L., Rhees B., et al. Changes in circulating microRNA levels associated with prostate cancer. Br J Cancer 2012, 106:768-774.
97. Hu Z., Chen X., Zhao Y., Tian T., Jin G., Shu Y., et al. Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer. J Clin Oncol 2010, 28:1721-1726.
98. Yu L., Todd N.W., Xing L., Xie Y., Zhang H., Liu Z., et al. Early detection of lung adenocarcinoma in sputum by a panel of microRNA markers. Int Journal Cancer 2010, 127:2870-2878.
99. Yamamoto Y., Kosaka N., Tanaka M., Koizumi F., Kanai Y., Mizutani T., et al. MicroRNA-500 as a potential diagnostic marker for hepatocellular carcinoma. Biomarkers 2009, 14:529-538.
100. Gui J., Tian Y., Wen X., Zhang W., Zhang P., Gao J., et al. Serum microRNA characterization identifies miR-885-5p as a potential marker for detecting liver pathologies. Clin Sci (Lond) 2011, 120:183-193.
101. Tsujiura M., Ichikawa D., Komatsu S., Shiozaki A., Takeshita H., Kosuga T., et al. Circulating microRNAs in plasma of patients with gastric cancers. Br J Cancer 2010, 102:1174-1179.
102. Zhou H., Guo J.M., Lou Y.R., Zhang X.J., Zhong F.D., Jiang Z., et al. Detection of circulating tumor cells in peripheral blood from patients with gastric cancer using microRNA as a marker. J Mol Med (Berl) 2010, 88:709-717.
103. Liu H., Zhu L., Liu B., Yang L., Meng X., Zhang W., et al. Genome-wide microRNA profiles identify miR-378 as a serum biomarker for early detection of gastric cancer. Cancer Letters 2012, 316:196-203.
104. Zhang C., Wang C., Chen X., Yang C., Li K., Wang J., et al. Expression profile of microRNAs in serum: a fingerprint for esophageal squamous cell carcinoma. Clin Chem 2010, 56:1871-1879.
105. Komatsu S., Ichikawa D., Takeshita H., Tsujiura M., Morimura R., Nagata H., et al. Circulating microRNAs in plasma of patients with oesophageal squamous cell carcinoma. Br J Cancer 2011, 105:104-111.
106. Wong T.S., Liu X.B., Wong B.Y., Ng R.W., Yuen A.P., Wei W.I., et al. Mature miR-184 as potential oncogenic microRNA of squamous cell carcinoma of tongue. Clin Cancer Res 2008, 14:2588-2592.
107. Liu C.J., Kao S.Y., Tu H.F., Tsai M.M., Chang K.W., Lin S.C., et al. Increase of microRNA miR-31 level in plasma could be a potential marker of oral cancer. Oral Dis 2010, 16:360-364.
108. Ho A.S., Huang X., Cao H., Christman-Skieller C., Bennewith K., Le Q.T., et al. Circulating miR-210 as a novel hypoxia marker in pancreatic cancer. Transl Oncol 2010, 3:109-113.
109. Li A., Omura N., Hong S.M., Vincent A., Walter K., Griffith M., et al. Pancreatic cancers epigenetically silence SIP1 and hypomethylate and overexpress miR-200a/200b in association with elevated circulating miR-200a and miR-200b levels. Cancer Res 2010, 70:5226-5237.
110. Morimura R., Komatsu S., Ichikawa D., Takeshita H., Tsujiura M., Nagata H., et al. Novel diagnostic value of circulating miR-18a in plasma of patients with pancreatic cancer. Br Journal Cancer 2011, 105:1733-1740.
111. Miyachi M., Tsuchiya K., Yoshida H., Yagyu S., Kikuchi K., Misawa A., et al. Circulating muscle-specific microRNA, miR-206, as a potential diagnostic marker for rhabdomyosarcoma. Biochem Biophys Res Commun 2010, 400:89-93.
112. Kanemaru H., Fukushima S., Yamashita J., Honda N., Oyama R., Kakimoto A., et al. The circulating microRNA-221 level in patients with malignant melanoma as a new tumor marker. J Dermatological Science 2011, 61:187-193.